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ABSTRACT: 
Background:
 
 Viruses can enter cells through several mechanisms, two common ones being 
clathrin-mediated and caveolin-mediated endocytosis.  The clathrin pathway delivers viral 
particles to endosomes, with subsequent acidification of the endosome and endosome/lysosome 
fusion often a prerequisite for release of the viral genome into the cytoplasm. The caveolin-
mediated pathway delivers virus initially into vesicles called caveosomes, which have a neutral 
pH, before viral uncoating occurs.  Viral entry pathways can be examined by using various drugs 
to inhibit the different endocytosis pathways, as well as by siRNA technology to down-regulate 
expression of clathrin or caveolin proteins on the surface of host cells.  
Methods:
 
 To evaluate the possible importance of clathrin- and caveolin-mediated entry 
pathways for mouse hepatitis virus (MHV) entry into cells, several inhibitors of clathrin-
mediated endocytosis were used to inhibit infection with MHV.  In addition, transfection with 
siRNA specific for clathrin or caveolin was used to monitor how down-regulation of these 
cellular proteins affect viral gene expression. The efficiency of siRNA transfection was 
determined by western blot analysis and real time reverse transcriptase polymerase chain 
reaction (RT2-PCR) using TaqMan gene expression assays. The abilities of recombinant virus 
expressing fusion proteins from two separate strains of MHV (MHV-A59 and MHV-2) to enter 
both mouse fibroblast cells (L2 cells) and brain-derived endothelial cells (bEnd cells) was 
evaluated by RT2-PCR for viral specific sequences generated within the first round of viral 
replication.  
Results: We confirmed that surface expression of caveolin and clathrin can be inhibited by 
siRNAs specific for these proteins. Down-regulation of these two proteins had a similar affect on 
viral gene expression for both strains of MHV. However, viral entry, as reflected by viral-
specific mRNA levels, was not diminished in siRNA transfected cells to the same extent as it 
was by the use of drugs specific for clathrin-mediated entry. Inhibitors of clathrin-mediated 
endocytosis demonstrated differing affects in the two cell lines, as well as differences between 
the two strains of MHV.  
Conclusions:
 
 Data from cells treated with inhibitors of clathrin-mediated endocytosis, as well as 
from siRNA experiments, indicate differences in entry mechanisms utilized by MHV in the two 
cell lines.  
